Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Dynavax Defends Strategic Direction, Highlights Vaccine Leadership And Capital Returns In Proxy Fight With Deep Track

Author: Benzinga Newsdesk | May 12, 2025 07:36am
  • Presentation Underscores Deep Track's Value Destructive Plan and Inferior Slate of Director Nominees
  • Urges Stockholders to Vote "FOR" All Four Dynavax Director Nominees on the GOLD Proxy Card Today

Posted In: DVAX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist